| Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo A Parekh, S Das, S Parida, CK Das, D Dutta, SK Mallick, PH Wu, ... Oncogene 37 (33), 4546-4561, 2018 | 75 | 2018 |
| Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition Y Rajesh, A Biswas, M Mandal Experimental cell research 359 (2), 299-311, 2017 | 46 | 2017 |
| Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management Y Rajesh, A Banerjee, I Pal, A Biswas, S Das, KK Dey, N Kapoor, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1863 (7), 1196-1209, 2019 | 31 | 2019 |
| Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma Y Rajesh, A Biswas, U Kumar, I Banerjee, S Das, S Maji, SK Das, ... Proceedings of the National Academy of Sciences 117 (22), 12324-12331, 2020 | 30 | 2020 |
| Targeting NFE2L2, a transcription factor upstream of MMP-2: a potential therapeutic strategy for temozolomide resistant glioblastoma Y Rajesh, A Biswas, U Kumar, S Das, I Banerjee, P Banik, R Bharti, ... Biochemical Pharmacology 164, 1-16, 2019 | 24 | 2019 |
| TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation BC Jena, CK Das, I Banerjee, D Bharadwaj, R Majumder, S Das, ... Experimental Cell Research 417 (1), 113195, 2022 | 21 | 2022 |
| ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors A Biswas, Y Rajesh, P Mitra, M Mandal Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1874 (1), 188389, 2020 | 21 | 2020 |
| Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma Y Rajesh, A Biswas, P Banik, I Pal, S Das, SA Borkar, H Sardana, A Saha, ... Oncotarget 11 (13), 1097, 2020 | 17 | 2020 |
| Push–pull stilbene: visible light activated photoremovable protecting group for alcohols and carboxylic acids with fluorescence reporting employed for drug delivery A Paul, A Biswas, S Sinha, SS Shah, M Bera, M Mandal, NDP Singh Organic letters 21 (9), 2968-2972, 2019 | 14 | 2019 |
| An insight into the ubiquitin-proteasomal axis and related therapeutic approaches towards central nervous system malignancies PK Roy, A Biswas, K Deepak, M Mandal Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (3), 188734, 2022 | 6 | 2022 |
| Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma A Biswas, Y Rajesh, S Das, I Banerjee, N Kapoor, P Mitra, M Mandal Cancer Letters 544, 215811, 2022 | 5 | 2022 |
| Fruity-scented antifungal volatiles from endophytic Geotrichum candidum PF005: broad-spectrum bioactivity against stored grain pathogens, mode of action and suitable … M Mitra, P Venkatesh, U Ghissing, A Biswas, A Mitra, M Mandal, ... Biological Control 177, 105129, 2023 | 4 | 2023 |
| Targeting ECM via stress associated regulation: A potential therapeutic avenue for overcoming temozolamide resistance in glioblastoma A Biswas, R Yetirajam, S Das, A Parekh, M Mandal New Biotechnology 44, S141-S142, 2018 | 2 | 2018 |
| Diosgenin and temozolamide: a potential combinatorial chemotherapy to overcome temozolamide resistance in glioblastoma multiforme Y Rajesh, A Biswas, S Das, M Mandal Cancer Research 77 (13_Supplement), 4105-4105, 2017 | 2 | 2017 |
